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The potential of receptor-mediated fluorescence-based image-
guided surgery tracers is generally linked to the near-infrared
emission profile and good-manufacturing-production availability of
fluorescent dyes. Surprisingly, little is known about the critical
interaction between the structural composition of the dyes and the
pharmacokinetics of the tracers. In this study, a dual-modality tracer
design was used to systematically and quantitatively evaluate the
influence of elongation of the polymethine chain in a fluorescent
cyanine dye on the imaging potential of a targeted tracer.Methods:
As a model system, the integrin marker αvβ3 was targeted using
arginylglycylaspartisc acid [RGD]–based vectors functionalized with
a 111In-diethylenetriaminepentaacetic acid (DTPA) chelate and a
fluorescent dye: (Cy3-(SO3)methyl-COOH [emission wavelength
(lem), 580 nm], Cy5-(SO3)methyl-COOH [lem, 680 nm], or Cy7-(SO3)
methyl-COOH [lem, 780 nm]). Tracers were analyzed for differences
in photophysical properties, serum protein binding, chemical or op-
tical stability, and signal penetration through tissue. Receptor affin-
ities were evaluated using saturation and competition experiments.
In vivo biodistribution (SPECT imaging and percentage injected
dose per gram of tissue) was assessed in tumor-bearing mice and
complemented with in vivo and ex vivo fluorescence images
obtained using a clinical-grade multispectral fluorescence laparo-
scope. Results: Two carbon-atom-step variations in the polyme-
thine chain of the fluorescent cyanine dyes were shown to
significantly influence the chemical and photophysical characteris-
tics (e.g., stability, brightness, and tissue penetration) of the hybrid
RGD tracers. DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK] structur-
ally outperformed its Cy3 and Cy7 derivatives. Radioactivity-based
evaluation of in vivo tracer pharmacokinetics yielded the lowest
nonspecific uptake and highest tumor-to-background ratio for
DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK] (13.2 ± 1.7), with the
Cy3 and Cy7 analogs trailing at respective tumor-to-background
ratios of 5.7 ± 0.7 and 4.7 ± 0.7. Fluorescence-based assessment
of tumor visibility revealed a similar trend. Conclusion: These find-
ings underline that variations in the polymethine chain lengths of
cyanine dyes have a profound influence on the photophysical prop-
erties, stability, and in vivo targeting capabilities of fluorescent
imaging tracers. In a direct comparison, the intermediate-length
dye (Cy5) yielded a superior c[RGDyK] tracer, compared with the
shorter (Cy3) and longer (Cy7) analogs.
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Within the nuclear medicine community, structural optimi-
zation of receptor-targeted radiotracers is a common good. Spe-
cific attention is paid to the influence of radiolabeling methods on
the tracer pharmacokinetics (1). When the generation of fluores-
cence tracers is being pursued, however, the limited ability to
quantify fluorescence tracer distribution (2) means that such stud-
ies are often ignored. As a result, fluorescent tracers are being
transferred to clinical trials without knowledge or reporting of
the whole-body kinetics (3–6). By including radiolabels on fluo-
rescence tracers, so-called dual-modality (bimodal or hybrid) trac-
ers are generated that allow quantitative mapping of the
pharmacokinetic properties (7). This concept has been success-
fully applied to nanoparticles, antibody analogs, and peptides
(8–13), as exemplified by the plurality of hybrid tracers in the
literature (14–17). For example, for the arginylglycylaspartic acid
(RGD) vector, it has been documented that the introduction of
different pendant moieties on an otherwise stable conjugated sys-
tem influences the pharmacokinetics (18–22).
The theoretic argument that near-infrared fluorescence emis-
sions (emission wavelength [lem], $750 nm) provide superior
tissue penetration has driven the use of reactive dyes such as
indocyanine green (ICG)-OSu, ZW800, and IRDye 800CW
(1,23,24). When these dyes are used to functionalize a targeting
vector, their tendency to stack, chemical instability, low fluores-
cence brightness, or relatively large size are generally not consid-
ered (25–27). Preclinical and clinical studies indicate that the
in-depth fluorescence imaging properties of slightly smaller far-
red dyes (e.g., the cyanine dye Cy5; lem, 650–750 nm) also sup-
port in vivo applications (28–30), including fluorescence-guided
surgery (3,31). In addition to providing an alternative to the use of
near-infrared dyes, adoption of other fluorescence wavelengths
also creates the potential for a multiparametric image-guidance
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process that supports the detection of two or more fluorescent
features in one patient (29,32).
In the unique design of cyanine dyes, wherein the length of the
polymethine chain that bridges the two indole units (being 3, 5,
and 7 carbon atoms long in Cy3, Cy5, and Cy7, respectively)
dictates the spectral properties of the dye. This feature allows the
creation of fluorescent tracers of which the spectral properties
can be specifically tuned for use alongside tracers of different
wavelengths. Whereas dye optimization currently focuses on
optimization of pendant moieties on cyanine dyes (18,33), the
influence of alterations in the length of the polymethine chain
has not yet been reported. To isolate the influence of the length
of the polymethine chain on overall tracer performance, the per-
formance of a previously optimized Cy5 dye (Cy5-(SO3)methyl-
COOH) (18) was systematically compared with its Cy3 and Cy7
analogs with identical pendant moieties. A hybrid RGD-tracer
design (Fig. 1) was used to directly link detailed evaluation of
the chemical properties (synthesis and chemical stability) and
photophysical properties (brightness and optical stability) of these
three tracers to their respective biologic properties (in vitro, in
vivo, and ex vivo) and imaging capabilities.
MATERIALS AND METHODS
The Cy3, Cy5, and Cy7 dyes and corresponding hybrid RGD
peptides were prepared and photophysically analyzed in line with
previous reports (18,34–37). Determination of photophysical proper-
ties and of stability (18,27,36,38), receptor affinity (15), and fluores-
cence confocal imaging (15) was performed as previously described.
The 4T1 tumor model was generated as previously described
(15,18,39). All animal experiments were in accordance with Dutch
welfare regulations and were approved by the local ethics committee
of the Leiden University Medical Center.
Isotope-Based Assessment of In Vivo Tracer Distribution
Radiolabeling of the diethylenetriaminepentaacetic acid (DTPA)
functionalized tracers DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK],
DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK], and DTPA-Cy7-(SO3)
methyl-COOH-c[RGDyK] with 111InCl3 and subsequent assessment
of labeling accuracy was performed as described previously (18),
using about 1 MBq for biodistribution (n 5 4) and 10–20 MBq for
SPECT imaging (n 5 2), followed by ex vivo evaluation of the bio-
distribution (in total, 6 animals per tracer). Imaging of 4T1 tumor–
bearing mice was performed on a U-SPECT scanner (MILabs) accord-
ing to previously described methods (18,39).
Quantitative biodistribution (percentage injected dose per gram of
tissue [%ID/g] and tumor-to-background ratio [T/B] [tumor-to-muscle
%ID/g]) were measured 24 h after injection and analyzed with a
relative performance scoring based on previously described proce-
dures (18).
In Vivo Fluorescence Imaging
The mice were sacrificed after SPECT imaging, followed by fluo-
rescence imaging performed using a preclinical IVIS Spectrum system
(Caliper Life Sciences) and a clinical-grade laparoscope setup (Storz
Endoskope GMBh) that allows multispectral imaging (30).
On the preclinical system, in vivo and ex vivo images of mice and
excised tissues were acquired at Cy3 (excitation wavelength [lex], 535
nm; lem, 580 nm), Cy5 (lex, 640 nm; lem, 680 nm), and Cy7 (lex, 745
nm; lem, 780 nm) settings. Quantitative analysis of the fluorescence in
the tissues (photons/s/cm2) and the T/B ratio was performed using the
Living Image software, version 3.2 (Caliper Life Sciences). For im-
aging with the fluorescence laparoscope, mice were placed on top of
an adjustable lift and imaged with a setup identical to that used to
evaluate the signal penetration of the fluorescent emissions (28–30).
Images were acquired using a clinical-grade IMAGE 1 S camera
equipped with a 0 laparoscope. Excitation was achieved using a D-
Light C light source (autofluorescence/fluorescein), a Cy5-modified
D-Light C light source (Cy5), and a prototype D-Light P light source
(ICG) (all Karl Storz). Built-in emission filters for Cy3 (autofluores-
cence mode) and Cy7 (ICG mode; catalog no. 26003AGA; Karl Storz)
were used for detection of either Cy3 or Cy7. Cy5 was detected by
placement of an additional standard eyepiece adaptor (catalog no.
20100034; Karl Storz) between the camera and the laparoscope (30).
Statistical Data Analysis
Analytic data were expressed as mean 6 SD as calculated using
Microsoft Excel software. The significance of 2 mean values was
calculated using a Student t test. The level of significance was set at
a P value of 0.05.
RESULTS
Synthesis of CyX-(SO3)Methyl-COOH Dyes and DTPA-CyX-
c[RGDyK] Tracers
The ease of synthesis was highest for Cy5-(SO3)methyl-COOH.
Although Cy7-(SO3)methyl-COOH could also be synthesized
FIGURE 1. (A) Schematic visualization of mouse in which tumor is illuminated by hybrid c[RGDyK] tracer. (B) The 3 different cyanine dyes (Cy3 in
orange, Cy5 in red, and Cy7 in blue) and their visible and fluorescence colorations as depicted by Karl Storz laparoscopic setup.
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using a good-manufacturing-production–compatible solid support
(see supplemental materials, available at http://jnm.snmjournals.
org), reduced reactivity of the reagent for the elongated polyme-
thine chain was observed. The preparation of Cy3-(SO3)methyl-
COOH was most complex, probably because of the increased
tendency of Cy3 (or trimethine) dyes to exist in the cis-state. In
thermodynamic terms, that causes unfavorable steric influences
(40). Conjugation of the dyes to the DTPA-containing dipeptide again
was most efficient for Cy5; a 25% yield was achieved for DTPA-Cy5-
(SO3)methyl-COOH-c[RGDyK], whereas DTPA-Cy5-(SO3)methyl-
COOH-c[RGDyK] and DTPA-Cy7-(SO3)methyl-COOH-c[RGDyK]
conveyed only a 10% and 19% yield, respectively.
Photophysical Properties of the Dyes and Complete Tracers
Differences in photophysical properties were observed between
the hybrid c[RDGyK] tracers (Table 1 (36,38); Supplemental Fig. 1)
and between the hybrid tracers and the unconjugated dyes (Fig. 2;
Supplemental Fig. 2; Supplemental Table 1). Absorption and emis-
sion were slightly lower for Cy7-(SO3)methyl-COOH than for the
reference dye ICG (Supplemental Fig. 3A).
Perhaps most striking was the variation in the quantum yield, in
which the order of superiority was DTPA-Cy5-(SO3)methyl-COOH-
c[RGDyK] (19%) . DTPA-Cy7-(SO3)methyl-COOH-c[RGDyK]
(11%) . DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK] (3%), as well
as Cy5-(SO3)methyl-COOH-SH (13%) . Cy7-(SO3)methyl-COOH-
SH (9%). Cy3-(SO3)methyl-COOH-SH (1%). The steric promotion
to the less favorable cis-isomer significantly impaired the quantum
yield of DTPA-Cy3-(SO3)methyl-COOH-SH and Cy3-(SO3)methyl-
COOH-SH (Fig. 2; Supplemental Figs. 1 and 2; Table 1; Supplemental
Table 1) (41).
Serum Protein Binding
Serum protein binding studies with the unconjugated dyes and
the hybrid c[RGDyK] tracers (Fig. 3A) revealed a 40% decrease in
serum binding for DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK]
compared with the unconjugated Cy5 derivative (36% vs. 76%).
A similar effect was observed for DTPA-Cy7-(SO3)methyl-COOH-
c[RGDyK], for which serum binding decreased by 34% within the
hybrid construct (55% vs. 89%). For DTPA-Cy3-(SO3)methyl-
COOH-c[RGDyK] (55%), no clear differences were seen between
the hybrid tracer and the unconjugated Cy3 derivative (58%).
TABLE 1








lex/lem in H2O and PBS
(Stokes shift)
547/565 (18 nm) 644/663 (19 nm) 745/770 (25 nm)
lex/lem in albumin (200 mg/mL)
(Stokes shift)
552/570 (18 nm) 653/668 (15 nm) 761/779 (18 nm)
FF in PBS 3%* 19%† 11%‡
FF in albumin (200 mg/mL) 6%¶ 23%¶ 12%¶
Brightness relative to Cy3
PBS 1 6 42
Albumin 1 4
Calculated log D§ −18.02 −17.49 −16.96
*Relative quantum yield compared with Cy3-(SO3)COOH-(SO3)COOH in PBS (FF 5 4%) (38).
†Relative quantum yield compared with Cy5-(SO3)COOH-(SO3)COOH in PBS (FF 5 27%) (38).
‡Relative quantum yield compared with Cy7-(SO3)Et-(SO3)COOH in PBS (FF 5 13% (39).
¶Relative increase in total fluorescence compared with FF measured in PBS, without consideration of solvent refractivity.
§Calculated for pH 7.4 with MarvinSketch (version 15.11.9; ChemAxon) using consensus approach.
lex/lem 5 excitation and emission wavelengths, respectively; FF 5 quantum yield; PBS 5 phosphate-buffered saline.
Photophysical properties of dyes alone are depicted in Supplemental Table 1.
FIGURE 2. Photophysical properties of (SO3)methyl-COOH dyes. Ab-
sorption and emission spectra of Cy3-(SO3)methyl-COOH (orange), Cy5-
(SO3)methyl-COOH (red), and Cy7-(SO3)methyl-COOH (blue) in phosphate-
buffered saline (A) and in 200mg/mL solution of albumin in water (B). Dotted
lines reveal red-shift in emission after addition of albumin. Photophysical
properties of hybrid tracers are provided in Supplemental Figure 1.
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Stability of Unconjugated Dyes and Hybrid Tracers
Assessment of the fluorescence intensity before and after
30 min of excitation revealed a good photostability for both DTPA-
Cy3-(SO3)methyl-COOH-c[RGDyK] and DTPA-Cy5-(SO3)methyl-
COOH-c[RGDyK], as the intensity loss for both tracers remained
below 14% (Supplemental Fig. 4). For DTPA-Cy7-(SO3)methyl-
COOH-c[RGDyK], the fluorescence intensity decreased by 50%,
indicating that the length of the polymethine chain is related to dye
stability.
Although the dyes and hybrid constructs all proved to be stable
under nucleophilic attack, a 57% decrease in absorbance and
fluorescence signal in serum was seen for DTPA-Cy7-(SO3)methyl-
COOH-c[RGDyK] (Supplemental Figs. 5–7). No change in absor-
bance was seen for DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK]
or DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK]. Regarding the fluo-
rescence emission, the fluorescence of DTPA-Cy3-(SO3)methyl-
COOH-c[RGDyK] was not altered, and only a 2% decrease in
fluorescence signal was seen for DTPA-Cy5-(SO3)methyl-COOH-
c[RGDyK].
Signal Penetration of Fluorescence Emissions
The in-depth detectability of the dyes was studied using videorate
recordings from a clinical-grade fluorescence laparoscope (Fig. 3B)
(29,30). Cy5-(SO3)methyl-COOH was shown to have signal penetra-
tion of up to 12 mm (as visibly detectable on screen). This visibility
was superior to that of the near-infrared dyes Cy7-(SO3)methyl-
COOH (9 mm) and ICG (7.5 mm; Supplemental Fig. 3B) and the
dye Cy3-(SO3)methyl-COOH (detectable only
when not covered by tissue).
Receptor Affinity and Binding
Localization
With receptor affinities of 37.8 6 9 nM
for Cy3, 39.0 6 11 nM for Cy5, and 48 6
9.5 nM for Cy7, affinity for anb3 integrin
was similar for all three hybrid tracers (Fig.
3C). Fluorescence confocal microscopy
revealed that focal cytoplasmic uptake of
DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK]
and DTPA-Cy5-(SO3)methyl-COOH-c
[RGDyK] overlapped with the localization
of lysosomes (Supplemental Fig. 8). Unfor-
tunately, the Cy7 dye in DTPA-Cy7-(SO3)
methyl-COOH-c[RGDyK] could not be ef-
fectively excited by the lasers incorporated
within the available microscopy setups (max-
imum excitation, 670 nm), underlining the
complexity of performing in vitro studies
with near-infrared dyes.




All three hybrid tracers enabled in vivo
lesion discrimination using SPECT (Fig. 4A).
Uptake of radioactivity in the tumor was 2.66




COOH-c[RGDyK]. Together with the %ID/g uptake in the adjoining
muscle tissue, a corresponding T/B ratio of 13.2 6 1.7 was found for
111In-DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK], 5.7 6 0.7 for
111In-DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK], and 4.7 6 0.7
for 111In-DTPA-Cy7-(SO3)methyl-COOH-c[RGDyK] (P , 0.001;
Fig. 4B).
In vivo fluorescence imaging and fluorescence-based evaluation
of the T/B ratio (Supplemental Fig. 9) revealed a comparable
Cy5 . Cy3 . Cy7 trend, although with a greater difference be-
tween values (10.89 6 1.2 . 1.28 6 0.3 . 0.99 6 0.6, respec-
tively; P , 0.001). These differences in T/B ratio agreed with the
intraoperative visibility of the tumors using a laparoscopic setup
(Fig. 4C).
Quantitative scoring of the relative performance of the Cy3 and
Cy7 derivatives, compared with 111In-DTPA-Cy5-(SO3)methyl-
COOH-c[RGDyK] (Supplemental Tables 2 and 3), further under-
lined the superiority of the Cy5 derivate.
DISCUSSION
Underlining and extending previous reports that alterations
in the pendant moieties on cyanine dyes affect tracer pharma-
cokinetics, the presented data reveal similar effects on tracer
kinetics after the length of the polymethine chain was varied in
cyanine dyes with identical pendant moieties. This finding provides
yet another feature to consider when pursuing the utility of a
tracer in fluorescence-guided surgery.
FIGURE 3. Protein binding, tissue penetration, and receptor affinity. (A) Protein binding in serum
of free CyX-(SO3)methyl-COOH dyes and DTPA-CyX-(SO3)methyl-COOH-c[RGDyK] tracers
(DTPA-CyX-c[RGDyK], dashed bars; *P , 0.005). (B) Tissue penetration of Cy3-(SO3)methyl-
COOH (orange), Cy5-(SO3)methyl-COOH (red), and Cy7-(SO3)methyl-COOH (blue), diluted in
albumin and measured with clinical-grade laparoscopic fluorescence camera. (C) Saturation
binding curve of DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK]. (D) Competition binding curves of
DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK] and DTPA-Cy7-(SO3)methyl-COOH-c[RGDyK].
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Alteration of the length of the polymethine chain in otherwise
identical cyanine dyes affected many features. The influence of
alteration on rotational freedom around the polymethine bond
within the cyanine dye (41) was reflected by variation in the
photophysical properties of both the unconjugated dyes and the
hybrid c[RGDyK] tracers (Table 1; Supplemental Table 1; Sup-
plemental Fig. 4). The five atoms in the polymethine chain of the
Cy5 analog seemed to produce the optimal degree of freedom,
resulting in the highest quantum yield and both good chemical
stability and good optical stability.
The chemical variation among the dyes affected the in-
teraction with albumin and serum, as revealed by differences in
quantum yield (Fig. 3A; Table 1; Supplemental Table 1), but
also altered the in vivo pharmacokinetics (Fig. 4), as is attribut-
able to the differences in protein binding among the tracers.
While overall binding to albumin increased the quantum yield
of both the unconjugated dyes (Supplemental Table 1) and the
hybrid constructs (Table 1), the degree of nonspecific tissue
uptake increased with increasing levels of protein binding
(Cy5 , Cy3 , Cy7; Figs. 3A and 3B) (15). Together, these
findings underline that interaction of dye with albumin affects
the biodistribution, bioactivity, and metabolism of a compound
(42–44). However, as the level of protein binding of the Cy3
and Cy7 conjugates was shown to be highly similar, the differ-
ence in biodistribution between these tracers cannot be solely
explained through this interaction. The increased dye lipophi-
licity of Cy7 compared with Cy3 (Table 1; Supplemental
Table 1), however, seems to reveal an amplifying effect on
the level of nonspecific uptake (45).
The hybrid nature of the tracers allowed imaging using both
radioactivity and fluorescence, as well as quantitative %ID/g
assessments using radioactivity (Fig. 4; Supplemental Fig. 9; Sup-
plemental Tables 2 and 3) (46,47). Interestingly, whereas radioac-
tivity-based assessment revealed a 2.3- to 2.8-fold higher T/B ratio
for 111In-DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK] than for the
Cy3 and Cy7 derivatives (Fig. 4B), fluorescence-based assessment
revealed an 8.4- to 9.1-fold higher ratio (Supplemental Fig. 9);
only the Cy5 analog yielded a T/B of more than 2. The 3-fold
difference between improvements determined using a radioactive
readout and improvements determined using a fluorescence read-
out seems to be related to a combination of the superior brightness
of the Cy5 dye (Table 1; Supplemental Table 1), the tissue pene-
tration of the Cy5 fluorescence signal (Fig. 3B), and the compat-
ibility of this dye with the fluorescence imaging modality used.
The ability to sensitively detect Cy5 and Cy7 with the prototype
Karl Storz fluorescence laparoscope (48) provides a promising
extension of its previously proven ability to image fluorescein
and ICG in a clinical setting ([29]).
In addition to the analysis steps described above, translation
from molecule to man also favors the use of Cy5, because such
far-red dyes are compatible with preclinical flow cytometers,
fluorescence (confocal) microscopes, and clinical and preclinical
fluorescence imaging systems (Fig. 3C; Supplemental Figs. 8 and
9B) (47). A lack of compatibility of near-infrared dyes with, for
FIGURE 4. Comparison of in vivo biodistribution of hybrid c[RGDyK] tracers with fluorescent components with polymethine chains of different
lengths. (A) In vivo SPECT image of 111In-DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK] (Cy3), of 111In-DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK] (Cy5),
and of 111In-DTPA-Cy7-(SO3)methyl-COOH-c[RGDyK] (Cy7) at 24 h after tracer injection. K 5 kidney; L 5 liver; T 5 tumor (encircled in red). (B)
Quantified biodistribution based on %ID/g of excised tissue (radioactivity-based) for 111In-DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK] (orange), 111In-
DTPA-Cy5-(SO3)methyl-COOH-c[RGDyK] (red), and 111In-DTPA-Cy3-(SO3)methyl-COOH-c[RGDyK] (blue). Determination of T/B was based on
%ID/g in tumor and adjoining muscle tissue. (C) Accompanying in vivo fluorescence images obtained using clinical-grade fluorescence camera
at 2-cm distance. Imaging and biodistribution analyses were performed at 24 h after injection. Images obtained with preclinical fluorescence scanner
are provided in Supplemental Fig. 9.
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example, common confocal microscopes can be considered a lim-
iting factor during the in vitro stages of tracer evaluation.
Combined, the reported findings advocate careful selection of
dye during the development of receptor-targeted fluorescence-
guided surgery applications. The fact that modest chemical
variation induces significant effects on tracer performance also
underlines the assumption that there is no such thing as a one-dye-
suits-all solution to cover the complexity and plurality of targeting
vectors explored for image-guided surgery (18). Our findings also
underline the need for accurate (and quantitative) analysis of
tracer pharmacokinetics, something that is made possible using
hybrid tracer designs. Given the clinical potential demonstrated
by hybrid tracers such as ICG-99mTc-nanocolloid (10,46,49–51),
adhering to such designs may also help improve clinical tracer
implementation in image-guided surgery trials.
CONCLUSION
The length of the polymethine chain in cyanine dyes exerts a
direct influence on the chemical, photophysical, and biologic
properties of a tracer. In a c[RGDyK]-based model, the Cy5 analog
proved to be superior to the Cy3 (visible fluorescence) and Cy7
(near-infrared fluorescence) analogs in all respects.
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Erratum
In the article ‘‘Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Clas-
sification for the Interpretation of PSMA-Ligand PET/CT’’ by Eiber et al. (J Nucl Med. 2018;59:469–478), Table 2
contains two errors in the first column. miN1a should be miN1, and miN1b should be miN2. The authors regret the
error.
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